Hims & Hers Health is trading at €25.24, down 5.26%, as September U.S. inflation ran hotter than expected. - On October 14, headline CPI was 3.7% year over year versus a 3.6% forecast, renewing interest-rate concerns and weighing on equities. - The broader sell-off supports a macro-driven explanation, rather than a confirmed company-specific catalyst. - October 14 securities-class-action reports largely refer to the FTC case and July 29 share-price reaction, not a new explanatory event.